Metabolic responses of A549 lung cells to cisplatin and radiation exposure studied by 1H NMR spectroscopy by Ana F Ladeirinha et al.
POSTER PRESENTATION Open Access
Metabolic responses of A549 lung cells to
cisplatin and radiation exposure studied
by 1H NMR spectroscopy
Ana F Ladeirinha1,2*, Inês D Lamego2, Ana M Gil2, Joana B Melo1, Isabel M Carreira1, Iola F Duarte2
From 16th International Charles Heidelberger Symposium on Cancer Research
Coimbra, Portugal. 26–28 September 2010
This work aims to characterize the dynamic metabolic
responses of A549 lung tumor cells exposed to cisplatin
(CDDP) and to 6 Gy ionizing radiation over a period of
48h. Control and CDDP/radiation treated cells, in the
form of lysed suspensions, were directly analyzed by 1H
High Resolution Magic Angle Spinning (HRMAS) NMR
spectroscopy (500 MHz) and the changes in their intra-
cellular metabolic profiles assessed by spectral integra-
tion and multivariate analysis. In this way, consistent
variation patterns could be detected and specific meta-
bolic effects related to drug and/or radiation exposure
could be identified. In particular, significant time-
dependent alterations were found in lipids and choline-
containing compounds, as well as in low molecular
weight metabolites such as some amino acids and nitro-
genated bases. The results presented show that 1H NMR
spectroscopy is a powerful tool for providing detailed
biochemical information about the effects induced on
cultured cells by external perturbations, such as a che-
motherapy drug and ionizing radiation. In the future,
this approach will be applied to lung cancer primary
cultures subjected to different treatment regimens.
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